TruChoice Launches New Online Calculators 17-02-2023, 01:03

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia 21-09-2024, 15:15

Latest generation of ORBCOMM®’s dry container monitoring solution can detect unauthorized container access, identify possible fires and reveal container damage 12-11-2024, 13:00